404 related articles for article (PubMed ID: 17033655)
1. Biotech patents and the inequitable conduct doctrine.
Michael A
Nat Biotechnol; 2006 Oct; 24(10):1219-21. PubMed ID: 17033655
[No Abstract] [Full Text] [Related]
2. Biotech patents: looking backward while moving forward.
Eisenberg RS
Nat Biotechnol; 2006 Mar; 24(3):317-9. PubMed ID: 16525404
[No Abstract] [Full Text] [Related]
3. US Supreme Court decision could compromise biotech patents.
Robertson D
Nat Biotechnol; 2001 May; 19(5):394. PubMed ID: 11328981
[No Abstract] [Full Text] [Related]
4. Patent first, ask questions later: morality and biotechnology in patent law.
Bagley MA
William Mary Law Rev; 2003 Dec; 45(2):469-547. PubMed ID: 15570677
[TBL] [Abstract][Full Text] [Related]
5. European Commission rethinks biotech patents.
Mitchell P
Nat Biotechnol; 2002 Dec; 20(12):1175-6. PubMed ID: 12454654
[No Abstract] [Full Text] [Related]
6. Obviousness, hindsight and perspective: the impact of KSR v. Teleflex on biotech and pharmaceutical patents.
Teitelbaum R; Cohen M
Nat Biotechnol; 2007 Oct; 25(10):1105-6. PubMed ID: 17921990
[No Abstract] [Full Text] [Related]
7. Patenting biotech beyond the central dogma.
Wu G
Nat Biotechnol; 2010 Mar; 28(3):230-3. PubMed ID: 20212482
[No Abstract] [Full Text] [Related]
8. Biotechnology. Lawsuit challenges legal basis for patenting human genes.
Marshall E
Science; 2009 May; 324(5930):1000-1. PubMed ID: 19460975
[No Abstract] [Full Text] [Related]
9. Biotech patents-business as usual?
Lawrence S
Nat Biotechnol; 2008 Dec; 26(12):1326. PubMed ID: 19060861
[No Abstract] [Full Text] [Related]
10. The CREATE Act: increasing costs associated with the biotech industry?
Mills AE; Chen DT; Gillon JJ; Tereskerz PM
Nat Biotechnol; 2006 Jul; 24(7):785-6. PubMed ID: 16841059
[TBL] [Abstract][Full Text] [Related]
11. Is the viability of the Lilly doctrine on the decline?
Walker BW; Carty SM
Nat Biotechnol; 2003 Aug; 21(8):943-4. PubMed ID: 12894207
[No Abstract] [Full Text] [Related]
12. Supreme Court boosts licensees in biotech patent battles.
Waltz E
Nat Biotechnol; 2007 Mar; 25(3):264-5. PubMed ID: 17344866
[No Abstract] [Full Text] [Related]
13. Intellectual property. Decision on NFkappaB patent could have broad implications for biotech.
Garber K
Science; 2006 May; 312(5775):827. PubMed ID: 16690824
[No Abstract] [Full Text] [Related]
14. The 'Lilly doctrine' is viable and critical.
Caltrider SP; Kelley JJ
Nat Biotechnol; 2003 Oct; 21(10):1131-2. PubMed ID: 14520388
[No Abstract] [Full Text] [Related]
15. Proposed changes to patent code loom over biotech industry.
Coombs A
Nat Biotechnol; 2007 Dec; 25(12):1333-4. PubMed ID: 18066010
[No Abstract] [Full Text] [Related]
16. Patent reform acts ugly.
Nat Biotechnol; 2007 Nov; 25(11):1187. PubMed ID: 17989652
[TBL] [Abstract][Full Text] [Related]
17. US court bolsters biotech patent protection.
Harrison C
Nat Biotechnol; 2011 Aug; 29(8):672-3. PubMed ID: 21822224
[No Abstract] [Full Text] [Related]
18. Napster case spills into biotech sector.
Bouchie A
Nat Biotechnol; 2004 Sep; 22(9):1185-6. PubMed ID: 15384189
[No Abstract] [Full Text] [Related]
19. Recent US patent legislation: what's new for biotech?
Gogoris AC; Todaro JC
Nat Biotechnol; 2000 Feb; 18(2):229-31. PubMed ID: 10657135
[TBL] [Abstract][Full Text] [Related]
20. Biotech patents: the world is your oyster--or mouse--or (you name it).
Alix JE
Technol Health Care; 1996 Sep; 4(3):255-8. PubMed ID: 8931235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
